Sign in

CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company

CalciMedica, Inc.

Sign in to watch
Ticker
CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452120079
Phone
858-952-5500
Business address
505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
Former names
CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
  1. 4 Open-market buy Director bought 506 shares at $3.30 ($1,670)
  2. 4 Open-market buy Chief Executive Officer bought 2,000 shares at $3.34 ($6,680)
  3. 4 Open-market buy Chief Business Officer bought 2,400 shares at $3.12 ($7,488)
  4. 4 Open-market buy Chief Business Officer bought 14,949 shares at an average $2.82 ($42,095)
  5. 4 Open-market buy Chief Executive Officer bought 2,440 shares at $3.12 ($7,615)
  6. 4 Open-market buy Chief Medical Officer bought 36,000 shares at $2.74 ($98,600)
  7. 4 Open-market buy Chief Business Officer bought 9,060 shares at an average $2.74 ($24,788)
  8. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $2.85 ($14,250)
  9. 4 Grant or award 10% owner acquired 1,640,044 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4/A Open-market buy Chief Business Officer bought 223 shares at $3.02 ($673)
  12. 4 Open-market buy Chief Business Officer bought 736 shares at $3.18 ($2,340)
  13. 4 Open-market buy Chief Business Officer bought 2,464 shares at an average $3.26 ($8,022)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chief Business Officer bought 1,900 shares at an average $3.59 ($6,822)
  19. 4 Open-market buy Chief Business Officer bought 2,500 shares at an average $4.27 ($10,675)
  20. 4/A Open-market buy Chief Executive Officer bought 1,000 shares at $5.23 ($5,225)

Page 7 of 14 · 266 filings